Nov. 29, 2021 — Merck’s antiviral pill for COVID-19, molnupiravir, appears to be far less effective than early results from the clinical trial first suggested. According to an analysis by scientists at the FDA, the experimental pill cut the risk of hospitalization or death from COVID-19 by about 30%, compared to a placebo, and the … Read more
The company stopped clinical trials early because initial results for the drug were so positive. Source link
The tablet – molnupiravir – will be given twice a day to patients recently diagnosed with the disease. Source link
Robin Foster, HealthDay Reporter FRIDAY, Oct. 1, 2021 (HealthDay News) — Pharmaceutical giant Merck & Co. said Friday that it will seek federal approval for emergency use of its new antiviral pill molnupiravir, after a clinical trial showed the drug halved the risk of hospitalization or death when given to high-risk people shortly after infection … Read more
Promising results mean a clinical trial has ended early and emergency authorisation is being sought. Source link
By JoNel Aleccia, Kaiser Health News Friday, September 24, 2021 (Kaiser News) — Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble breathing, symptoms serious enough to send her to … Read more
By Dennis Thompson HealthDay Reporter WEDNESDAY, Sept. 1, 2021 (HealthDay News) — A four-in-one pill containing “ultra-low doses” of different medications can provide better blood pressure control than standard drug treatment, a new clinical trial from Australia shows. About 80% of people given the “quadpill” achieved a healthy blood pressure of 140/90 within three months … Read more
Dr Asha Kasliwal, president of the Faculty of Sexual and Reproductive Healthcare, said: “Progestogen-only contraceptive pills are safe, reliable, easy to use and are an incredibly popular contraceptive method. Availability over the counter in pharmacies will make it easier for women to access essential contraception to avoid unplanned pregnancies during and beyond Covid-19.” Source link
April 13, 2021 — A requirement that mifepristone abortion pills be dispensed only in-person by a medical provider will be put on hold during the COVID-19 pandemic, the U.S. Food and Drug Administration says. The decision means that health care providers in some states will be able to prescribe mifepristone via telemedicine and mail the … Read more
The contraception could be sold without prescription for the first time, following a public consultation. Source link